News

According to the U.S. Food and Drug Administration (FDA), injectable human growth hormone (HGH) is only approved for "clearly and narrowly defined" medical conditions and must be prescribed

Aripiprazole lauroxil is an investigational, new, once-monthly, long-acting injectable atypical antipsychotic. The NDA is based on the positive results from the randomized, multicenter, double-blind, placebo-controlled, phase III trial

The financing round included new investors Adage Capital Management, LP, OrbiMed Advisors, Partner Fund Management, LP, Rock Springs Capital, and Sofinnova Ventures, with participation from all existing investors,

PD-L1 (SP142) rabbit monoclonal antibody is for research use only (RUO) and has been developed for Roche/Genentech’s anti-PD-L1 (MPDL3280A) immunotherapy development program as well as in research of

GBM is the most common and most aggressive malignant primary brain tumor in humans. Insys Therapeutics president and chief executive officer Michael Babich said the company is happy

Both the firms have not disclosed financial details of the deal, under which Eurolab has agreed to specific annual commercial goals for Brinavess. Cardiome chief commercial officer Karim

These novel drug compositions consisting of noncoding doubled stranded RNA (dsRNA) molecules and recombinant immunoglobulin-peptide (IgP) molecules demonstrate unique immune stimulating activity, and the ability to present peptide

Covagen’s lead product COVA 322, a bispecific anti-tumor necrosis factor (TNF)-alpha/anti-interleukin (IL)-17A FynomAb, is currently in a Phase Ib trial for psoriasis. COVA 322 is also said to

In October 2013, Zorvolex was approved by the FDA to treat mild to moderate acute pain in adults. The prescription-based Zorvolex is the first FDA-approved low dose NSAID